Expert Opinion on Drug Safety

Title Publication Date Language Citations
Janus kinase inhibitor—Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data2023/09/18English
Comparative efficacy and safety of different doses of ponatinib versus other tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia: a systematic review and network meta-analysis2023/10/26English
Ondansetron induced blindness: a pharmacovigilance database study2023/10/24English
Cardiac arrhythmias associated with anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)2023/07/10English
Expert consensus on the clinical application of ormutivimab injection for use against the rabies virus2023/07/12English
Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system2023/08/24English
Safety of selinexor as the only exportin 1 (XPO1) inhibitor so far: a post-marketing study based on the world Health Organization pharmacovigilance database (Vigibase)2023/08/22English
Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes2023/08/03English
Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda2023/08/08English
Interstitial lung disease risk of anaplastic lymphoma kinase tyrosine kinase inhibitor treatment of non-small cell lung cancer: a real-world pharmacovigilance study2023/08/12English
Proton pump inhibitors use prior to COVID-19 hospitalization is associated with higher C lostridioides difficile infection rate2023/07/10English
Comparison of safety of acetaminophen and ibuprofen in minors: based on the FAERS database2024/04/30English
Evaluation of the safety and efficacy of biosimilar recombinant growth hormone in children with growth hormone deficiency: non-inferiority, randomized, parallel, multicentric and Phase III trial2024/04/29English
Signal detection of adverse reactions for bendamustine based on FDA adverse event reporting system2024/04/30English
Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database2024/04/29English
Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension2022/04/28English
Adverse events of guselkumab in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system2023/06/13English
Epidemiological investigation of emergency infusion adverse drug reactions in Nanjing, China: a prospective cross-sectional study2023/06/13English
A drug safety evaluation of pemigatinib for advanced cholangiocarcinoma2023/06/26English
Sodium-glucose cotransporter-2 inhibitors and cardiovascular safety profile: a pharmacovigilance analysis of the US food and drug administration adverse event reporting system2023/05/26English
Real-world safety profile of riluzole: a systematic analysis of data from the FAERS database and case reports2023/06/13English
The evolution of real-world evidence in healthcare decision making2023/06/03English
Insights into efficacy and safety of dapagliflozin treatment for the management in older adults with type 2 diabetes: a systematic review and meta-analysis2023/01/09English
Lack of association between febrile seizures and vaccines containing diphtheria, tetanus, and acellular pertussis in Chinese children2022/08/25English
Renal drug dosage adjustments and adverse drug events in patients with chronic kidney disease admitted to the hospital: a cross-sectional study2024/02/08English
Anticancer drug-induced interstitial lung disease: a critical appraisal of clinical practice guidelines and consensus statements2024/02/20English
Risk of pancreatitis and pancreatic carcinoma for anti-diabetic medications: findings from real-world safety data analysis and systematic review and meta-analysis of randomized controlled trials2023/12/11English
A comparative safety review of targeted therapies for acute myeloid leukemia2023/12/02English
Newly identified adverse events for gemcitabine using the Food and Drug Administration Adverse Event Reporting System2023/11/20English
A real-world analysis of safety profile of selexipag by using FDA adverse Event Reporting System (FAERS)2023/12/05English